Skip to content
drillr.ai
Sign up

CRDL

Cardiol Therapeutics Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA

$2.20
+1.85%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue52.7K——187.4K162.2K
Gross Profit(52.7K)——(187.4K)(162.2K)
Operating Expenses
R&D Expense17.0M14.0M14.0M10.7M14.0M
SG&A Expense22.1M20.2M25.9M11.6M16.3M
General & Admin Expense17.4M20.2M25.9M——
Selling & Marketing Expense—————
Other Expenses51.5K102.0K373.1K——
Total Operating Expenses39.2M34.3M40.3M22.3M30.3M
Cost and Expenses39.2M34.3M40.3M22.5M30.5M
Operating Income (EBIT)(39.2M)(34.3M)(40.3M)(22.5M)(30.5M)
Non-Operating
Interest Income784.8K726.4K1.2M2.0M1.2M
Interest Expense—————
Net Interest Income784.8K726.4K1.2M2.0M1.2M
Other Non-Op Income/Expense2.3M497.4K3.6M1.3M7.7M
Non-Operating Income (excl Interest)(2.3M)(497.4K)(3.6M)(1.3M)(7.7M)
EBT (Pre-Tax Income)(37.0M)(33.8M)(36.7M)(21.2M)(22.8M)
Income Tax Expense—————
Bottom Line
Net Income(36.7M)(33.8M)(36.7M)(21.2M)(22.8M)
Earnings from Cont. Ops(37.0M)(33.8M)(36.7M)(21.2M)(22.8M)
Earnings from Discont. Ops—————
Bottom Line Net Income(36.7M)(33.8M)(36.7M)(21.2M)(22.8M)
Per Share
Basic EPS($0.36)($0.39)($0.51)($0.44)($0.49)
Diluted EPS($0.36)($0.39)($0.51)($0.44)($0.49)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding114.9M87.0M71.6M64.5M62.5M
Diluted Shares Outstanding114.9M87.0M71.6M64.5M62.5M
Profitability Metrics
EBITDA(36.9M)(33.7M)(36.5M)(21.0M)(22.7M)
D&A78.3K102.0K162.1K187.4K162.2K
EBIT(37.0M)(33.8M)(36.7M)(21.2M)(22.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026